Valuation Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Equities

End-of-day quote Shanghai S.E. Other stock markets 22/01/2026			5-day change	1st Jan Change
59.44 ^CNY	-1.10%		-6.56%	-0.22%

01-13	Hengrui Pharma Unit Secures Approval to Conduct Clinical Trial for Hypertension Drug	MT
01-13	Hengrui Pharma's Cancer Drug Obtains China Breakthrough Therapy Designation	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	591,745	323,076	245,741	287,598	291,858	395,427	395,427	-
Change	-	-45.4%	-23.94%	17.03%	1.48%	35.49%	0%	-
Enterprise Value (EV) ¹	580,941	309,445	231,891	266,852	267,083	356,612	349,789	341,804
Change	-	-46.73%	-25.06%	15.08%	0.09%	33.52%	-1.91%	-2.28%
P/E ratio	93.7x	71.4x	63.2x	66.5x	45.9x	44.5x	40.4x	33.3x
PBR	19.5x	9.27x	6.5x	7.13x	6.43x	6.49x	5.73x	5.04x
PEG	-	-2.5x	-4.5x	5.8x	1x	1.3x	4x	1.6x
Capitalization / Revenue	21.3x	12.5x	11.6x	12.6x	10.4x	11.9x	10.7x	9.22x
EV / Revenue	20.9x	11.9x	10.9x	11.7x	9.54x	10.8x	9.48x	7.97x
EV / EBITDA	77.6x	63.6x	49.2x	47.1x	32.1x	35.5x	31.4x	25.4x
EV / EBIT	82.9x	66.3x	56.4x	54.3x	35.7x	37.1x	32.6x	26.1x
EV / FCF	202x	120x	-328x	43.2x	48.8x	49.7x	38.2x	31.1x
FCF Yield	0.5%	0.83%	-0.3%	2.32%	2.05%	2.01%	2.62%	3.22%
Dividend per Share ²	0.1667	0.16	0.16	0.2	0.2	0.2813	0.3203	0.3797
Rate of return	0.18%	0.32%	0.42%	0.44%	0.44%	0.47%	0.54%	0.64%
EPS ²	0.9917	0.71	0.61	0.68	1	1.335	1.471	1.784
Distribution rate	16.8%	22.5%	26.2%	29.4%	20%	21.1%	21.8%	21.3%
Net sales ¹	27,735	25,906	21,275	22,820	27,985	33,156	36,915	42,901
EBITDA ¹	7,483	4,868	4,717	5,666	8,308	10,058	11,139	13,467
EBIT ¹	7,007	4,665	4,112	4,910	7,491	9,616	10,742	13,092
Net income ¹	6,328	4,530	3,906	4,302	6,337	8,757	9,772	11,798
Net Debt ¹	-10,805	-13,631	-13,850	-20,746	-24,775	-38,816	-45,639	-53,624
Reference price ²	92.88	50.71	38.53	45.23	45.90	59.44	59.44	59.44
Nbr of stocks (in thousands)	6,370,846	6,371,045	6,377,915	6,358,560	6,358,560	6,624,271	6,624,271	-
Announcement Date	19/04/21	22/04/22	21/04/23	17/04/24	30/03/25	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.03x	10.9x	35.87x	0.46%	57.39B
ELI LILLY AND COMPANY	47.02x	15.57x	34.69x	0.55%	966B
JOHNSON & JOHNSON	21.28x	5.87x	16.32x	2.37%	525B
ABBVIE INC.	61.3x	7.19x	17.25x	3.03%	382B
ROCHE HOLDING AG	20.66x	5.03x	12.45x	2.87%	371B
ASTRAZENECA PLC	27.47x	5.12x	15.18x	1.81%	278B
NOVARTIS AG	20.12x	5.35x	12.54x	2.85%	276B
MERCK & CO., INC.	14.15x	4.64x	9.98x	2.91%	276B
NOVO NORDISK A/S	16.19x	5.74x	11.86x	3.11%	260B
AMGEN INC.	26.85x	6.32x	10.82x	2.78%	185B
Average	30.01x	7.17x	17.70x	2.27%	357.66B
Weighted average by Cap.	32.58x	8.44x	19.81x	2.08%